2016's Top 10 Trials
Kim A. Eagle, MD, MACC, editor-in-chief of ACC.org, and Deepak L. Bhatt, MD, MPH, FACC, senior associate editor of ACC.org, share their picks for the top 10 cardiovascular trials of 2016. Do you agree? Share your top 2016 trials on Twitter with @ACCinTouch using #CVTop10.
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, Valvular Heart Disease, Atherosclerotic Disease (CAD/PAD), Anticoagulation Management and Atrial Fibrillation, Implantable Devices, EP Basic Science, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Cardiac Surgery and VHD, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and Coronary Artery Disease, Interventions and Imaging, Interventions and Structural Heart Disease, Angiography, Nuclear Imaging, Sleep Apnea
Keywords: ACC Publications, Cardiology Magazine, Absorbable Implants, Alzheimer Disease, American Heart Association, Angiography, Angiotensin-Converting Enzyme Inhibitors, Animals, Antibodies, Monoclonal, Anticoagulants, Arteries, Aspirin, Atrial Appendage, Atrial Fibrillation, Benzazepines, Biological Markers, Calcium, Cardiomyopathies, Cardiovascular Diseases, Consensus, Coronary Artery Disease, Coronary Stenosis, Critical Pathways, DNA, Defibrillators, Diabetes Mellitus, Electronic Health Records, Epidemiologic Studies, Evidence-Based Medicine, Exons, Explosions, Factor Xa, Follow-Up Studies, Glucose, Habits, Health Care Reform, Health Personnel, Health Promotion, Heart Failure, Heart Valve Diseases, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Injections, Subcutaneous, Investments, Lipids, Male, Medication Adherence, Mitral Valve, Morals, Muscular Dystrophy, Duchenne, Myocardial Infarction, Myocardium, National Heart, Lung, and Blood Institute (U.S.), Natriuretic Peptide, Brain, Needles, Medical Oncology, Patient Care Team, Patient Protection and Affordable Care Act, Peptide Fragments, Pharmaceutical Preparations, Pharmacogenetics, Plaque, Atherosclerotic, Point-of-Care Systems, RNA Interference, Regeneration, Registries, Return to Work, Risk Assessment, Risk Factors, Secondary Prevention, Sesamum, Social Responsibility, Stents, Stroke, Tachycardia, Ventricular, Transcatheter Aortic Valve Replacement, Uncertainty, United States Food and Drug Administration, Vaccination
< Back to Listings